First look: Guide your compound design strategy with new visual, industry-leading affinity predictions
Accurate predictions of binding affinity are the holy grail of early-phase discovery, enabling teams to significantly reduce the synthesis and…
In this webinar, Peter Hunt and Matthew Segall examine the effective use of QSAR modelling in drug discovery and discuss a variety of pain points for medicinal chemists in knowing when a model can be trusted and how to avoid common pitfalls. We discuss key learning points for the successful use of QSAR models and how they can be used to make better decisions in a multi-parameter optimisation workflow to select and design high-quality compounds for your projects.
Topics for discussion include:
Accurate predictions of binding affinity are the holy grail of early-phase discovery, enabling teams to significantly reduce the synthesis and…
Science shouldn’t be a solo act. And now, with StarDrop 8 available and ready to use, it never has to be. Learn how you…
Accurate QSAR models lead to more efficient and cost-effective molecular discovery. Better predictions enable you to prioritise the optimal compounds…